Linkedin Facebook Twitter Youtube

19 Jul Center for Gene Therapy at the Abigail Wexner Research Insitute, Nationwide Children’s Hospital

Posted at 19:01h in by

Matthew McFarland, Ph.D., Vice President of Commercialization and Industry Relations

Oct. 11 | 1:15pm | Ecolab Life Sciences Ballroom 

Columbus, Ohio

(Private)

The Center for Gene Therapy is focused on the translational development of gene therapies for inherited disorders. The Institute has a long history of engagement with biotech partners, and research at the center has led to approved therapies for spinal muscular atrophy and Duchenne muscular dystrophy. A significant number of projects are underway at various stages of preclinical development, including ones directed towards new or improved approaches to DMD, limb-girdle muscular dystrophies, inherited neuropathies, and degenerative and developmental disease of the central nervous system.

www.nationwidechildrens.org/research/areas-of-research/center-for-gene-therapy



About the Event

The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures. Tackling the commercialization hurdles facing the cell and gene therapy sector today, this meeting covers a wide range of topics from clinical trial design to alternative payment models to scale-up and supply chain platforms for advanced therapies. The program features expert-led panels, extensive partnering capabilities, exclusive networking opportunities, and 100+ dedicated presentations by the leading publicly traded and privately held companies in the space. Attracting over 2,000 attendees – over 20% of which are C-level executives – this conference enables key partnerships through more than 5,000 one-on-one meetings while highlighting the significant clinical and commercial progress in the field.

Dates & Location

October 7-9, 2024
Arizona Biltmore
Phoenix, AZ

Program Organizer

By using this website you agree to accept our Privacy Policy and Terms & Conditions